UnknownNot applicableNCT03399175
Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
Studying Vogt-Koyanagi-Harada disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Sao Paulo
- Principal Investigator
- Joyce H Yamamoto, MDUniversity of Sao Paulo School of Medicine Ophthalmology
- Intervention
- Early high-dose corticosteroid and immunosuppressive therapy(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 10-70 years · All sexes
- Timeline
- 2015 – 2025
Study locations (1)
- Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo, São Paulo, São Paulo, Brazil
Collaborators
Fundação de Amparo à Pesquisa do Estado de São Paulo
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03399175 on ClinicalTrials.govOther trials for Vogt-Koyanagi-Harada disease
Additional recruiting or active studies for the same condition.